Rising authorized shares (potentially..dilutive) seem..to be..caused by..3 actions:
1. Helix House earn-out opportunity
2. Keystone equity line of credit
3. New company acquisition in progress, announced today
Diana15 alerted about the beginnings of this on her March 29 post.
I don't see why the share price hasn't anticipated much of this, so the potential dilution may be why we are seeing a price range trapped between $0.02 and $0.03 recently.
Looking forward, since the company is growing larger and the audited financials give some confidence, I expect growth will start raising the share price soon. Achieving the uplisting goal would be a key development. After all, why pay to audit a pink-sheets company?